Burkitt Lymphoma is a type of cancer that starts in the cells of the immune system, specifically B-cells. It's a fast-growing cancer often found in the abdomen or jaw. It's named after Dr. Georges Kosciejewsky, who first described it in 1952.
Every report comes from a Lived member, sent anonymously.
Have you tried Rituximab for Burkitt Lymphoma?
Burkitt lymphoma is a rare, very fast-growing cancer of B cells, the white blood cells that normally make antibodies. It is a type of non-Hodgkin lymphoma, and it is one of the fastest-growing cancers known: a tumor can enlarge noticeably over days to weeks. For that reason, treatment needs to start quickly once it is diagnosed. The same speed also makes it highly responsive to chemotherapy, and many people are cured. In the United States it most often appears as a mass in the abdomen, typically involving the bowel, causing pain, swelling or a blockage. It can also affect the ovaries, kidneys, the tissue at the back of the throat, testicles, bone marrow and the brain and spinal fluid. In parts of Africa, a form that usually involves the jaw or facial bones of children is far more common. When most of the disease is in the bone marrow and blood, it is called Burkitt leukemia, but it is the same illness and is treated the same way. Burkitt lymphoma is most common in children, teenagers and young adults, and it affects males more often than females. It accounts for about 40% of non-Hodgkin lymphoma in US children but only a small share of lymphoma in adults.
The defining event in every case is a rearrangement of the MYC gene, which controls cell growth. A piece of chromosome 8 carrying MYC swaps places with a chromosome that holds an antibody gene, switching MYC permanently on and driving the cells to divide nonstop. This change happens inside the lymphoma cells during a person's life. It is not inherited and cannot be passed to children. What triggers the rearrangement is not fully understood. A weakened immune system clearly raises the risk: Burkitt lymphoma is more common in people with HIV (human immunodeficiency virus) and in people who have had an organ transplant. Infection with Epstein-Barr virus (EBV, the virus behind mononucleosis) is found in nearly all cases of the African form but in only about 15% of cases in the United States and Europe. Since EBV infection is extremely common and Burkitt lymphoma is rare, having had the virus does not mean someone is likely to develop it.
Diagnosis requires a biopsy, a sample of the tumor examined under a microscope and with genetic tests. Pathologists look for B cells that are dividing at an extremely high rate and confirm the MYC gene rearrangement. That genetic finding separates Burkitt lymphoma from look-alikes such as high-grade B-cell lymphoma (once called Burkitt-like lymphoma), which can need a different approach. Because the disease spreads quickly, staging is done promptly. It usually includes a PET-CT scan, which combines a CT scan with a tracer that highlights active tumor, to map where the lymphoma is, a bone marrow biopsy, and a lumbar puncture (spinal tap) to check whether lymphoma cells are in the fluid around the brain and spinal cord. Blood tests check kidney function, uric acid and lactate dehydrogenase (LDH), an enzyme released by fast-growing tumors. A high LDH reflects a larger tumor burden and helps doctors judge risk and plan treatment intensity. Adults are typically tested for HIV, since the result changes treatment.
Treatment is intensive combination chemotherapy, several drugs given in short, closely spaced cycles, usually over a few months. For most people it is combined with rituximab (Rituxan or a biosimilar), an antibody that attaches to a protein on B cells and helps the immune system destroy them. In a large trial of children and teens with advanced disease, adding rituximab raised the share who stayed free of lymphoma from about 82% to 94%. Regimens are more intense than those used for most other lymphomas, and the exact plan depends on age, stage and overall health. People with HIV and older adults may receive modified regimens designed to be less toxic, alongside HIV treatment where relevant. Burkitt lymphoma has a strong tendency to reach the brain and spinal fluid, so nearly everyone also receives chemotherapy injected directly into the spinal fluid (intrathecal chemotherapy), whether or not lymphoma is found there, to prevent or treat that spread. The first days of treatment need particular care. Chemotherapy can kill tumor cells so fast that their contents flood the blood, a problem called tumor lysis syndrome, which can damage the kidneys and disturb heart rhythm. Treatment therefore usually starts in the hospital with large volumes of intravenous fluids, medicines that lower uric acid and frequent blood tests. Surgery is used mainly to obtain a biopsy or relieve a bowel blockage, though a small, fully removed tumor in a child may need less chemotherapy afterward. Radiation is rarely part of first treatment. If the lymphoma returns, options include different chemotherapy, a stem cell transplant, CAR T-cell therapy (in which a person's own immune cells are engineered to attack the lymphoma) or a clinical trial.
The outlook with modern treatment is good for many people. About 9 in 10 children and teenagers are cured. Adults also do well, especially younger adults: in large studies about 7 in 10 were alive and lymphoma-free several years later. Outcomes are less favorable for people over about 40, those with lymphoma in the brain or spinal fluid, those with a very high LDH and those who are seriously ill at diagnosis. Treatment is demanding. Expect repeated hospital stays, often a central line (a long-term IV catheter) for medicines and blood draws, and periods of very low blood counts when infections, mouth sores, fatigue and the need for transfusions are common. Serious complications can occur, and some people die from treatment rather than the lymphoma, so care is usually given at centers experienced with this disease. Most people cannot keep a normal work or school schedule during treatment, and practical support for caregivers matters. Because the lymphoma grows so fast, relapses tend to happen early, mostly within the first year or two. Someone who remains in remission beyond that point is very likely cured. Follow-up visits and scans are most frequent at first. Survivors, particularly those treated as children, need longer-term checkups for late effects such as fertility problems, heart strain from some chemotherapy drugs, and a small risk of second cancers. Fertility preservation is worth raising before treatment begins, when time allows.
See a clinician soon about swelling or pain in the abdomen that keeps growing, a painless lump in the neck, armpit, groin or a testicle, or unexplained fevers, drenching night sweats or weight loss. These usually have other causes, but because this lymphoma grows quickly, a lump that gets visibly bigger over days or a week deserves prompt evaluation rather than waiting. During chemotherapy, call the care team right away, at any hour, for a temperature of 100.5 F (38 C) or higher, shaking chills, or redness or swelling where a central line enters the skin. Infection when blood counts are low can become life threatening quickly. Also call promptly for passing much less urine than usual, vomiting that prevents drinking fluids, or severe abdominal pain, which can signal kidney strain or a bowel complication.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Burkitt Lymphoma is like, what's helped you, or ask the community a question.